CVS Health Eyes Margin Recovery, Cash Flow as 2027 Headwinds Loom

CVS Health NYSE: CVS executives said the company is seeing improved momentum across its insurance, pharmacy, care delivery and balance-sheet priorities, while maintaining a cautious outlook on healthcare cost trends and several 2027 headwinds.

MarketBeat • Sep 10, 2026

CVS Health: Buy The Pullback Before Earnings Power Ramps Up

CVS Health trades at a discounted 12x forward P/E versus peers, despite robust business momentum and integrated healthcare assets. Q2 2026 saw 7% YoY revenue growth to $106B and 35% adjusted operating income growth, signaling a turnaround in earnings power. Aetna margin restoration, specialty pharmacy growth, and GLP-1 expansion offset risks from elevated medical costs and regulatory headwinds.

Seeking Alpha • 21 hours ago

CVS Health Corporation (CVS) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

CVS Health Corporation (CVS) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Seeking Alpha • 21 hours ago

Should You Buy, Hold or Sell CVS Stock Amid Consumer Wellness Growth?

CVS is benefiting from pharmacy growth, AI investments and a discounted valuation, but reimbursement pressure and regulatory scrutiny remain key risks.

Zacks Investment Research • 18 hours ago

Here are the stocks to favor in the fourth quarter — and those you should avoid

Large caps tend to outperform small caps as year's end approaches.

Market Watch • 12 hours ago

Wall Street Loves CVS Health Stock Right Now. Should You?

CVS Health has significantly improved its business since last year. The company is performing well financially as a result.

The Motley Fool • Sep 9, 2026

CVS Still Sees 'High-Trend' Cost Growth; Oscar, UNH Stock Fall

Here's why Oscar Health may be taking comments from CVS on the chin.

Investors Business Daily • Sep 9, 2026

CVS Health marks 20 years of free community health screening program as new survey reveals many U.S. adults still face barriers to preventive health screenings

WOONSOCKET, R.I., Sept. 9, 2026 /PRNewswire/ -- New survey findings commissioned by CVS Health® (NYSE: CVS) reveal that many Americans face persistent barriers accessing preventive health screenings.

PRNewsWire • Sep 9, 2026

Here's Why CVS Health (CVS) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Sep 9, 2026

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

Zacks Investment Research • Sep 9, 2026